Tools vs. Demand

Peter Zeihan concludes that U.S. tools can disrupt drug networks, but demand-side issues limit effectiveness.

Play episode from 09:29

Transcript

The AI-powered Podcast Player

Save insights by tapping your headphones, chat with episodes, discover the best highlights - and more!